Instituto Butantan to Produce CoronaVac Vaccine in Brazil, an Industrial Info Market Brief
Brazilian state company Instituto Butantan, with the financial support of Fundacao Butantan, is investing around $31 million at its Sao Paulo plant to produce 1.2 million units of the CoronaVac vaccine for COVID-19.
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
